Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Spectrum Pharmaceuticals, Inc.
  6. News
  7. Summary
    SPPI   US84763A1088

SPECTRUM PHARMACEUTICALS, INC.

(SPPI)
  Report
Delayed Nasdaq  -  05/26 04:00:00 pm EDT
0.7053 USD   -0.63%
05/26Spectrum Pharmaceuticals to Present Data at 2022 ASCO Highlighting the Potential Predictive Capabilities of ctDNA as a Biomarker for Poziotinib Treatment Response
BU
05/25SPECTRUM PHARMACEUTICALS : Current Corporate Presentation
PU
05/17SPECTRUM PHARMACEUTICALS INC Change in Directors or Principal Officers (form 8-K/A)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Spectrum Pharmaceuticals to Get $20 Million Equity Investment from Hanmi Pharmaceutical

01/04/2022 | 07:55am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about SPECTRUM PHARMACEUTICALS, INC.
05/26Spectrum Pharmaceuticals to Present Data at 2022 ASCO Highlighting the Potential Predic..
BU
05/25SPECTRUM PHARMACEUTICALS : Current Corporate Presentation
PU
05/17SPECTRUM PHARMACEUTICALS INC Change in Directors or Principal Officers (form 8-K/A)
AQ
05/17SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers, Financial Statem..
AQ
05/17Spectrum Pharmaceuticals to Participate in H.C. Wainwright Global Investment Conference
BU
05/12TRANSCRIPT : Spectrum Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12SPECTRUM PHARMA : Q1 Earnings Snapshot
AQ
05/12Spectrum Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corp..
BU
05/12Spectrum Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended Mar..
CI
05/11Spectrum Pharmaceuticals Names Nora Brennan CFO
MT
More news
Analyst Recommendations on SPECTRUM PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2022 7,29 M - -
Net income 2022 -90,9 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,39x
Yield 2022 -
Capitalization 124 M 124 M -
Capi. / Sales 2022 17,0x
Capi. / Sales 2023 1,10x
Nbr of Employees 164
Free-Float 89,8%
Chart SPECTRUM PHARMACEUTICALS, INC.
Duration : Period :
Spectrum Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SPECTRUM PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 0,71 $
Average target price 5,60 $
Spread / Average Target 694%
EPS Revisions
Managers and Directors
Thomas J. Riga President, CEO, CFO & Director
William L. Ashton Chairman
Francois Lebel Chief Medical Officer & Executive Vice President
Lyndah K. Dreiling Senior Vice President-Clinical Development
Dolatrai M. Vyas Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SPECTRUM PHARMACEUTICALS, INC.-44.46%124
MODERNA, INC.-46.53%54 016
LONZA GROUP AG-28.07%42 292
IQVIA HOLDINGS INC.-26.37%39 319
SEAGEN INC.-10.44%25 487
ICON PUBLIC LIMITED COMPANY-29.73%17 693